Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is W  [Clear All Filters]
Journal Article
Abi-Gerges N, McMahon C, Vargas H, Sager P, Chui R, Stevens D, Davila J, Schaub JR, Wu JC, Del Rio C, et al. The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment. J Pharmacol Toxicol Methods. 2019:106582.
Cai X, Zheng Y, Speck NA. A Western Blotting Protocol for Small Numbers of Hematopoietic Stem Cells. J Vis Exp. 2018;(138).
Majidi SSeidelin, Adamsen PSlemming, Hanif M, Zhang Z, Wang Z, Chen M. Wet electrospun alginate/gelatin hydrogel nanofibers for 3D cell culture. Int J Biol Macromol. 2018.
Wang C-Y, Sartika D, Wang D-H, Da Hong P-, Cherng J-H, Chang S-J, Liu C-C, Wang Y-W, Wu S-T. Wet-spinning-based Molding Process of Gelatin for Tissue Regeneration. J Vis Exp. 2019;(145).
Swick A, Kimple RJ. Wetting the whistle: neurotropic factor improves salivary function. J Clin Invest. 2014:1-3.
Su Q, Yuan F, Li X, Wang X, Yang K, Shao L, Li W. Wfs1 loss-of-function disrupts the composition of mouse pancreatic endocrine cells from birth and impairs Glut2 localization to cytomembrane in pancreatic β cells. Biochem Biophys Res Commun. 2023;658:80-87.
Tai P, Chen X, Jia G, Chen G, Gong L, Cheng Y, Li Z, Wang H, Chen A, Zhang G, et al. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. J Transl Med. 2023;21(1):823.
Koken GYildirim, Abamor EŞefik, Diyev AAllahver, Karaöz E. WHARTON JELLY DERIVED MESENCHYMAL STEM CELL's EXOSOMES DEMONSTRATE SIGNIFICANT ANTILEISHMANIAL AND WOUND HEALING EFFECTS IN COMBINATION WITH ALOE-EMODIN: AN IN VITRO STUDY. J Pharm Sci. 2022.
Abbasi S, Bazyar R, Saremi MAli, Alishiri G, Seyyedsani N, Jadid MFarhoudi S, Khorrami A, Golmarz PEmami, Jahangirzadeh G, Bedoustan ABabazadeh, et al. Wharton jelly stem cells inhibits AGS gastric cancer cells through induction of apoptosis and modification of MAPK and NF-κB signaling pathways. Tissue Cell. 2021;73:101597.
Aratikatla A, Maffulli N, Gupta M, Potti IA, Potty AG, Gupta A. Wharton's jelly and osteoarthritis of the knee. Br Med Bull. 2023.
Kalaszczynska I, Ferdyn K. Wharton's Jelly Derived Mesenchymal Stem Cells: Future of Regenerative Medicine? Recent Findings and Clinical Significance. Biomed Res Int. 2015;2015:430847.
Varaa N, Azandeh S, Khodabandeh Z, Gharravi AMohammad. Wharton's Jelly Mesenchymal Stem Cell: Various Protocols for Isolation and Differentiation of Hepatocyte-Like Cells; Narrative Review. Iran J Med Sci. 2019;44(6):437-448.
Drobiova H, Sindhu S, Ahmad R, Haddad D, Al-Mulla F, Madhoun AAl. Wharton's jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications. Front Cell Dev Biol. 2023;11:1211217.
Mokhtari T, Shayan M, Rashnudi ARezaei, Hassanzadeh G, Nia KMehran. Wharton's jelly mesenchymal stem cells attenuate global hypoxia-induced learning and memory impairment via preventing blood-brain barrier breakdown. Iran J Basic Med Sci. 2023;26(9):1053-1060.
Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, et al. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation. Regen Med. 2014;9(6):723-732.
Cheng T, Yang B, Li D, Ma S, Tian Y, Qu R, Zhang W, Zhang Y, Hu K, Guan F, et al. Wharton's Jelly Transplantation Improves Neurologic Function in a Rat Model of Traumatic Brain Injury. Cell Mol Neurobiol. 2015.
Penolazzi L, Chierici A, Notarangelo MPina, Dallan B, Lisignoli G, Lambertini E, Greco P, Piva R, Nastruzzi C. Wharton's jelly-derived multifunctional hydrogels: New tools to promote intervertebral disc regeneration in vitro and ex vivo. J Biomed Mater Res A. 2024.
Pochon C, Notarantonio A-B, Laroye C, Reppel L, Bensoussan D, Bertrand A, Rubio M-T, D'Aveni M. Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation. J Cell Mol Med. 2022.
Anon. Wharton's Jelly-Mesenchymal Stem Cell-Engineered Conduit for Pediatric Translation in Heart Defect, by Iacobazzi, et al. Tissue Engineering Part A 2021;27(3-4):201-213; doi: 10.1089/ten.tea.2020.0088. Tissue Eng Part A. 2023.
Mudde ACa, Kuo CY, Kohn DB, Booth C. What a Clinician Needs to Know about Genome Editing: Status and Opportunities for Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2024.
Cytryn R, Bickell N, Yagnik R, Jagannath S, Lin JJ. What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study. Cancers (Basel). 2023;15(8).
Lalu MM, Foster M, Presseau J, Dowlatshahi D, Castillo G, Cardenas A, Tam W, Zlepnig J, Timpson D, Dong YYi, et al. What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study. BMJ Open. 2020;10(3):e034354.
Chandhanayingyong C, Thanapipatsiri P, Pairojboriboon S, Luenam S, Hongsaprabhas C, Charoenlap C, Wattanapaiboon K, Asavamongkolkul A, Tharmviboonsri T, Phimolsarnti R. What Are the MSTS Scores and Complications Associated With the Use of Three-dimensional Printed, Custom-made Prostheses in Patients Who Had Resection of Tumors of the Hand and Foot?. Clin Orthop Relat Res. 2023.
Pellman BA, Kim JJ. What Can Ethobehavioral Studies Tell Us about the Brain's Fear System?. Trends Neurosci. 2016.
Broeckel U. What Can hiPSC-Cardiomyocytes Teach Us about Modeling Complex Human Disease Phenotypes?. Cell Stem Cell. 2016;19(3):282-284.

Pages